Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.

Haque W, Verma V, Butler EB, Teh BS.

J Neurooncol. 2017 Oct;135(1):173-181. doi: 10.1007/s11060-017-2563-0. Epub 2017 Jul 7.

PMID:
28687924
2.

Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.

Amsbaugh MJ, Yusuf MB, Gaskins J, Burton EC, Woo SY.

Cancer. 2017 Sep 1;123(17):3277-3284. doi: 10.1002/cncr.30730. Epub 2017 Apr 27.

3.

Patterns of care and outcomes for glioblastoma in patients with poor performance status.

Malakhov N, Lee A, Garay E, Becker DJ, Schreiber D.

J Clin Neurosci. 2018 Jun;52:66-70. doi: 10.1016/j.jocn.2018.03.006. Epub 2018 Mar 22.

PMID:
29576419
4.

Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.

Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB.

Cancer. 2016 Aug 1;122(15):2364-70. doi: 10.1002/cncr.30063. Epub 2016 May 12.

5.

Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.

Haque W, Verma V, Butler EB, Teh BS.

Dis Esophagus. 2018 Jul 23. doi: 10.1093/dote/doy067. [Epub ahead of print]

PMID:
30052835
6.

Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.

Wang EH, Rutter CE, Corso CD, Decker RH, Wilson LD, Kim AW, Yu JB, Park HS.

J Thorac Oncol. 2015 Jun;10(6):937-43. doi: 10.1097/JTO.0000000000000519.

7.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
8.

Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.

Rhome R, Fisher R, Hormigo A, Parikh RR.

J Neurooncol. 2016 Jun;128(2):241-50. doi: 10.1007/s11060-016-2101-5. Epub 2016 Mar 12.

PMID:
26970981
9.

Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.

Shields LB, Shelton BJ, Shearer AJ, Chen L, Sun DA, Parsons S, Bourne TD, LaRocca R, Spalding AC.

Radiat Oncol. 2015 Oct 31;10:222. doi: 10.1186/s13014-015-0527-0.

10.

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Han SJ, Rutledge WC, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA.

Neurosurgery. 2015 Aug;77(2):248-53; discussion 253. doi: 10.1227/NEU.0000000000000766.

11.

Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.

Haque W, Verma V, Butler EB, Teh BS.

Am J Clin Oncol. 2018 Feb;41(2):167-172. doi: 10.1097/COC.0000000000000417.

PMID:
29369825
12.

Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.

Sun MZ, Oh T, Ivan ME, Clark AJ, Safaee M, Sayegh ET, Kaur G, Parsa AT, Bloch O.

J Neurosurg. 2015 May;122(5):1144-50. doi: 10.3171/2014.9.JNS14193. Epub 2015 Mar 13.

PMID:
25768833
13.

Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.

Rahman R, Catalano PJ, Reardon DA, Norden AD, Wen PY, Lee EQ, Nayak L, Beroukhim R, Dunn IF, Golby AJ, Johnson MD, Chiocca EA, Claus EB, Alexander BM, Arvold ND.

J Neurooncol. 2015 Aug;124(1):137-46. doi: 10.1007/s11060-015-1820-3. Epub 2015 Jun 2.

PMID:
26033544
14.

Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.

Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG.

J Radiat Res. 2018 Mar 1;59(suppl_1):i11-i18. doi: 10.1093/jrr/rrx103.

15.

Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.

Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D, Karikari IO, Grossi PM, Thomas S, Friedman AH, Adamson C.

J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.

PMID:
26452121
16.

Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.

Koshy M, Sher DJ, Spiotto M, Husain Z, Engelhard H, Slavin K, Nicholas MK, Weichselbaum RR, Rusthoven C.

J Neurooncol. 2017 Dec;135(3):529-534. doi: 10.1007/s11060-017-2598-2. Epub 2017 Aug 23.

PMID:
28836140
17.

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B.

Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38.

18.

A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.

Abhinav K, Aquilina K, Gbejuade H, La M, Hopkins K, Iyer V.

Clin Neurol Neurosurg. 2013 Aug;115(8):1375-8. doi: 10.1016/j.clineuro.2012.12.023. Epub 2013 Jan 18.

PMID:
23333005
19.

Impact of removed tumor volume and location on patient outcome in glioblastoma.

Awad AW, Karsy M, Sanai N, Spetzler R, Zhang Y, Xu Y, Mahan MA.

J Neurooncol. 2017 Oct;135(1):161-171. doi: 10.1007/s11060-017-2562-1. Epub 2017 Jul 6.

PMID:
28685405
20.

Contribution of low-molecular weight heparin addition to concomitant chemoradiotherapy in the treatment of glioblastoma multiforme.

Zincircioglu SB, Kaplan MA, Isikdogan A, Cil T, Karadayi B, Dirier A, Kucukoner M, Inal A, Yildiz I, Aggil F, Donmez O, Urakci Z, Pekkolay Z, Firat U.

J BUON. 2012 Jan-Mar;17(1):124-7.

PMID:
22517705

Supplemental Content

Support Center